Skip to content
2000
Volume 24, Issue 36
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

It is nowadays widely accepted that some tumors have a niche of cells endowed with stemness features, which may cause resistance to conventional anticancer therapies and relapse/recurrence of the malignancy. These cells are usually referred to as cancer stem cells (CSCs) and, different from normal cancer cells, are rather quiescent. Targeting CSCs is thus a highly challenging but promising strategy to counteract tumor growth, and to develop innovative anticancer agents. Here, we review the chemical, biological and multidisciplinary efforts that have been spent in targeting CSCsspecific signaling pathways Notch and Hedgehog (Hh) for anticancer drug discovery. In particular, the use of natural products as a valuable source of lead compounds or chemical biology tools is emphasized. Examples of natural products functionalization through semi-synthetic transformations or total syntheses, aimed at improving pharmacokinetics and/or pharmacodynamics properties of natural products in Notch or Hh inhibition, are provided as well.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612825666190111124822
2018-10-01
2025-07-14
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612825666190111124822
Loading

  • Article Type:
    Review Article
Keyword(s): Cancer; cancer stem cells; drug discovery; Hedgehog; inhibitors; natural products; Notch
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test